In the future, CD47-based optical molecular imaging could help surgeons make initial judgments about whether tumor tissue in fresh specimens has positive surgical margins or even be used for fluorescence-guided surgery to improve the thoroughness of tumor resection. Here, CD47 is linked to neoplasm.